Neil Belmore and Lindsay Neidrauer were successful in preventing Apotex from marketing a generic version of LEVAQUIN®. This appeal involved a procedural issue relating to abuse of process in respect of the generic’s allegations.
© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy